You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelofibrosis

Showing 1 - 25 of 670
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myelofibrosis Trial in France (Clonal architecture determination)

    Not yet recruiting
    • Myelofibrosis
    • Clonal architecture determination
    • Angers, France
    • +6 more
    Jan 24, 2023

    Assess Real-World Patient-Reported Outcomes With Fedratinib for

    Recruiting
    • Myelofibrosis
      • City, State, Austria
        Local Institution
      Dec 16, 2022

      Myelofibrosis Trial (Momelotinib)

      Available
      • Myelofibrosis
      • (no location specified)
      Oct 12, 2022

      Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

      Recruiting
      • Myelofibrosis; Anemia
      • +5 more
      • Jacksonville, Florida
      • +6 more
      Jan 3, 2023

      Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

      Recruiting
      • Myelofibrosis
      • Jaktinib Hydrochloride Tablets
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital of Medical School of Zhejiang Univ
      Nov 28, 2022

      Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

      Recruiting
      • Myelofibrosis
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital of Medical School of Zhejiang Univ
      Nov 28, 2022

      Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

      Not yet recruiting
      • Myelofibrosis
      • TQ05105 tablets
      • +2 more
      • Jinan, Shandong, China
        Shandong Provincial Hospital
      Aug 30, 2023

      Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 26, 2022

      Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)

      Not yet recruiting
      • Myelofibrosis
      • Jaktinib Hydrochloride Tablets
      • Changsha, Hunan, China
        The Third Hospital of Changsha
      Nov 9, 2023

      Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

      Not yet recruiting
      • Myelofibrosis
      • TQ05105 Tablets
      • TQB3617 Capsules
      • Guangzhou, Guangdong, China
      • +19 more
      Nov 7, 2023

      Myelofibrosis Trial in Hong Kong (Bomedemstat)

      Recruiting
      • Myelofibrosis
      • Hong Kong, Hong Kong
        Department of Medicine, the University of Hong Kong, Queen Mary
      Oct 3, 2022

      Myelofibrosis Trial in United States (Selinexor, Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Duarte, California
      • +4 more
      Jan 30, 2023

      Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

      Recruiting
      • Myelofibrosis
      • +2 more
      • Charlottesville, Virginia
        Danyelle Coley
      Jan 18, 2023

      Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

      Recruiting
      • Myelofibrosis Due to and Following Polycythemia Vera
      • Basking Ridge, New Jersey
      • +6 more
      Jan 26, 2023

      AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

      Not yet recruiting
      • AML
      • +5 more
      • Infusion of CD34 selected hematopoietic stem cells
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Sep 14, 2023

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Worcester, Massachusetts
      • +16 more
      Oct 31, 2022

      Myelofibrosis Trial in United States (Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Boston, Massachusetts
      • +4 more
      Oct 21, 2022